GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:11172060

From GONUTS
Jump to: navigation, search
Citation

Chen, JF, Moratalla, R, Impagnatiello, F, Grandy, DK, Cuellar, B, Rubinstein, M, Beilstein, MA, Hackett, E, Fink, JS, Low, MJ, Ongini, E and Schwarzschild, MA (2001) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 98:1970-5

Abstract

The A(2A)R is largely coexpressed with D(2)Rs and enkephalin mRNA in the striatum where it modulates dopaminergic activity. Activation of the A(2A)R antagonizes D(2)R-mediated behavioral and neurochemical effects in the basal ganglia through a mechanism that may involve direct A(2A)R-D(2)R interaction. However, whether the D(2)R is required for the A(2A)R to exert its neural function is an open question. In this study, we examined the role of D(2)Rs in A(2A)R-induced behavioral and cellular responses, by using genetic knockout (KO) models (mice deficient in A(2A)Rs or D(2)Rs or both). Behavioral analysis shows that the A(2A)R agonist 2-4-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine reduced spontaneous as well as amphetamine-induced locomotion in both D(2) KO and wild-type mice. Conversely, the nonselective adenosine antagonist caffeine and the A(2A)R antagonist 8-(3-chlorostyryl)caffeine produced motor stimulation in mice lacking the D(2)R, although the stimulation was significantly attenuated. At the cellular level, A(2A)R inactivation counteracted the increase in enkephalin expression in striatopallidal neurons caused by D(2)R deficiency. Consistent with the D(2) KO phenotype, A(2A)R inactivation partially reversed both acute D(2)R antagonist (haloperidol)-induced catalepsy and chronic haloperidol-induced enkephalin mRNA expression. Together, these results demonstrate that A(2A)Rs elicit behavioral and cellular responses despite either the genetic deficiency or pharmacological blockade of D(2)Rs. Thus, A(2A)R-mediated neural functions are partially independent of D(2)Rs. Moreover, endogenous adenosine acting at striatal A(2A)Rs may be most accurately viewed as a facilitative modulator of striatal neuronal activity rather than simply as an inhibitory modulator of D(2)R neurotransmission.

Links

PubMed PMC29366 Online version:10.1073/pnas.98.4.1970

Keywords

Adenosine/analogs & derivatives; Adenosine/pharmacology; Amphetamines/pharmacology; Animals; Caffeine/analogs & derivatives; Caffeine/pharmacology; Catalepsy/pathology; Corpus Striatum/metabolism; Corpus Striatum/pathology; Dopamine Antagonists/pharmacology; Enkephalins/biosynthesis; Enkephalins/genetics; Gene Expression; Haloperidol/pharmacology; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity/physiology; Phenethylamines/pharmacology; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; RNA, Messenger; Receptor, Adenosine A2A; Receptors, Dopamine D1/biosynthesis; Receptors, Dopamine D2/biosynthesis; Receptors, Dopamine D2/physiology; Receptors, Purinergic P1/biosynthesis; Receptors, Purinergic P1/physiology

Significance

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status


See also

References

See Help:References for how to manage references in GONUTS.